.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Healthtrust
Covington
Express Scripts
Boehringer Ingelheim
Chubb
McKinsey
Fish and Richardson
Harvard Business School
Deloitte

Generated: September 20, 2017

DrugPatentWatch Database Preview

Benazepril hydrochloride; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for benazepril hydrochloride; hydrochlorothiazide and what is the scope of benazepril hydrochloride; hydrochlorothiazide patent protection?

Benazepril hydrochloride; hydrochlorothiazide
is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Sandoz, Us Pharms Holdings I, Actavis Labs Fl Inc, Ivax Sub Teva Pharms, Sun Pharm Inds Ltd, Mylan, and Apotex Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for benazepril hydrochloride; hydrochlorothiazide. Twelve suppliers are listed for this compound.

Summary for Generic Name: benazepril hydrochloride; hydrochlorothiazide

Tradenames:2
Patents:0
Applicants:8
NDAs:8
Drug Master File Entries: see list14
Suppliers / Packagers: see list12
Clinical Trials: see list2,602
Drug Prices:see low prices
DailyMed Link:benazepril hydrochloride; hydrochlorothiazide at DailyMed

Pharmacology for Ingredient: benazepril hydrochloride; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076342-004Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-003May 19, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-001May 19, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-004May 19, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076342-002Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL077483-003Sep 8, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076348-002Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076348-001Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL077483-004Sep 8, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076631-001Feb 11, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: benazepril hydrochloride; hydrochlorothiazide

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Colorcon
Cipla
Daiichi Sankyo
Fuji
Mallinckrodt
Dow
Julphar
Medtronic
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot